INmune Bio Inc. (INMB)
NASDAQ: INMB
· Real-Time Price · USD
2.53
0.08 (3.27%)
At close: Aug 15, 2025, 3:59 PM
2.47
-2.37%
After-hours: Aug 15, 2025, 07:51 PM EDT
INmune Bio Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -24.46M | -9.74M | -9.22M | -12.09M | -9.75M | -11.03M | -8.41M | -8.56M | -6.5M | -6.54M | -5.83M | -7.72M | -6.84M | -6.9M | -9.67M | -9.46M | -6.66M | -4.56M |
Depreciation & Amortization | n/a | n/a | n/a | -24K | 24K | 34K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 1.53M | 2.08M | 1.76M | 1.72M | 2.35M | 1.78M | 1.88M | 1.89M | 1.86M | 1.74M | 1.79M | 1.94M | 1.89M | 1.54M | 1.52M | 1.61M | 769K | 899K |
Other Working Capital | -780K | 109K | 512K | 156K | 138K | 570K | -7.12M | 1.21M | 1.1M | 6.72M | -3.46M | 495K | 1M | -2.3M | -1.27M | -1.99M | -627K | -1.47M |
Other Non-Cash Items | 16.51M | n/a | 6K | 39K | n/a | n/a | 45K | 54K | 58K | 67K | 68K | 147K | 57K | 56K | 57K | 53K | 16K | 1.41M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -965K | 839K | -3.56M | 3.37M | -514K | 1.74M | 3.08M | 2.36M | 1.41M | 3.59M | -1.72M | 2.27M | 136K | -3.55M | -1.69M | -124K | 161K | -1.44M |
Operating Cash Flow | -7.38M | -6.82M | -11.01M | -6.99M | -7.89M | -7.48M | -3.4M | -4.26M | -3.17M | -1.14M | -5.7M | -3.37M | -4.76M | -8.87M | -9.78M | -7.92M | -5.71M | -5.09M |
Capital Expenditures | -706K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -15M | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 2.55M | -2.55M | n/a | n/a | n/a | n/a | n/a | n/a | -15M | n/a | -15M | n/a |
Investing Cash Flow | -706K | n/a | n/a | n/a | n/a | n/a | 2.55M | -2.55M | n/a | n/a | 699K | n/a | -699K | n/a | -15M | n/a | -15M | n/a |
Debt Repayment | n/a | n/a | -2.5M | -2.5M | -2.5M | -2.5M | -2.5M | -2.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 1K | 12.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 30K | 80.25M | 1.14M | 14.95M | 18K |
Financial Cash Flow | 22.27M | 5.27M | -2.08M | 9.79M | 13M | -2.5M | -2.5M | -1.73M | n/a | n/a | -699K | n/a | n/a | 729K | n/a | 52.94M | 14.95M | 28.46M |
Net Cash Flow | 14.04M | -1.58M | -12.63M | 2.48M | 5.07M | -9.85M | -5.96M | -6.01M | -3.18M | -1.15M | -5.25M | -3.81M | -5.52M | -8.08M | -9.66M | 44.95M | -5.82M | 23.37M |
Free Cash Flow | -8.08M | -6.82M | -11.01M | -6.99M | -7.89M | -7.48M | -3.4M | -4.26M | -3.17M | -1.14M | -5.7M | -3.37M | -4.76M | -8.87M | -9.78M | -7.92M | -20.71M | -5.09M |